| 000 | 01519 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512222816.0 | ||
| 264 | 0 | _c19850318 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0735-1631 | ||
| 024 | 7 |
_a10.1055/s-2007-1000055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuchs, A R | |
| 245 | 0 | 0 |
_aCervical ripening with intracervical prostaglandin-E2 gel. I. Clinical results and effect on plasma levels of oxytocin and 13,14-dihydro,15-ketoprostaglandin-F2 alpha. _h[electronic resource] |
| 260 |
_bAmerican journal of perinatology _cOct 1983 |
||
| 300 |
_a64-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCervix Uteri _xdrug effects |
| 650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
| 650 | 0 | 4 | _aDinoprostone |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLabor, Induced |
| 650 | 0 | 4 |
_aOxytocin _xblood |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Complications |
| 650 | 0 | 4 |
_aProstaglandins E _xadministration & dosage |
| 650 | 0 | 4 |
_aProstaglandins F _xblood |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUterine Contraction _xdrug effects |
| 700 | 1 | _aGoeschen, K | |
| 700 | 1 | _aRasmussen, A B | |
| 700 | 1 | _aRehnström, J V | |
| 700 | 1 | _aSaling, E | |
| 700 | 1 | _aFuchs, F | |
| 773 | 0 |
_tAmerican journal of perinatology _gvol. 1 _gno. 1 _gp. 64-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2007-1000055 _zAvailable from publisher's website |
| 999 |
_c6595935 _d6595935 |
||